Abstract:Alcoholic liver disease (ALD) is characterized by gut dysbiosis, higher hepatic and circulating levels of bile acids (BAs) and intestinal epithelial dysfunction. BA homeostasis is modulated by hepatic and intestinal nuclear farnesoid X receptor (FXR, Nr1h4), a ligand activated transcription factor, through regulating key genes involved in bile acid synthesis and metabolism. BA synthesis regulation by intestinal FXR is through induction of fibroblast growth factor 15 (FGF15) that inhibits hepatic Cyp7a1, the key gene in BA de novo synthesis. Previous studies showed that FXR expression is suppressed miR194 in various tissues. In this study, we investigated the regulation of FXR by miR194 in intestinal tissues in mice with ALD. C57BL6 and intestinal specific FXR knockout (FXRΔIEC) mice were subjected to the Lieber DeCarli liquid diet containing 5% alcohol for 10 days, and one bonus of alcohol (5 g/kg) was gavaged on last day 9 hours before tissue collecting. Control mice were fed isocaloric maltose dextrin. A group of mice was supplemented with Lactobacillus rhamnosus GG (LGG) at a dose of 109 CFU/day for 10 days before alcohol exposure. Alcohol feeding significantly increased hepatic fat accumulation and serum ALT and AST levels. Interestingly, the alcohol‐induced effects were associated with an increased expression of miR194 and a decreased expression of FXR and FGF15 in the intestine, and with an upregulation of hepatic Cyp7a1 and BA concentration. When the mice were supplemented with probiotic LGG, intestinal miR194 expression was suppressed, FXR‐FGF15 signaling pathway was upregulated, and hepatic BA levels were decreased. Alcohol induced hepatic steatosis and injury were markedly prevented by LGG. More importantly, the beneficial effects of LGG on hepatic BA homeostasis in ALD mice were diminished when the intestinal epithelial FXR was deleted. In vitro study showed that alcohol treatment increased miR194 and decreased FXR mRNA, and inhibition of miR194 attenuated the suppression of FXR mRNA by alcohol. Taken together, our results demonstrate that intestinal FXR‐FGF15 signaling plays a pivotal role in maintaining hepatic BA homeostasis in ALD mice and probiotic LGG protects against ALD through maintaining BA homeostasis regulated by intestinal miR194‐FXR‐FGF15‐mediated signaling pathways. Supported by grants from NIH.

Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency

FXR and TGR5 Agonists Ameliorate Liver Injury, Steatosis, and Inflammation After Binge or Prolonged Alcohol Feeding in Mice

Altered ethanol metabolism and increased oxidative stress enhance alcohol-associated liver injury in farnesoid X receptor-deficient mice

Intestinal MiR194 Regulates Hepatic Bile Acids through Intestinal FXR‐FGF15 Pathway in Alcoholic Liver Disease in Mice

Activation of Farnesoid X Receptor Attenuates Hepatic Injury in a Murine Model of Alcoholic Liver Disease.

Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice

Probiotic-derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation

Intestinal Farnesoid X Receptor Signaling Promotes Nonalcoholic Fatty Liver Disease

Farnesoid X receptor is an important target for the treatment of disorders of bile acid and fatty acid metabolism in mice with nonalcoholic fatty liver disease combined with cholestasis

Mice Lacking FXR Are Susceptible to Liver Ischemia-Reperfusion Injury

Kaempferol ameliorated alcoholic liver disease through inhibiting hepatic bile acid synthesis by targeting intestinal FXR-FGF15 signaling

Role of farnesoid X receptor and bile acids in alcoholic liver disease

Fibroblast Growth Factor 19 Alters Bile Acids to Induce Dysbiosis in Mice With Alcohol-Induced Liver Disease

Intestinal farnesoid X receptor signaling controls hepatic fatty acid oxidation

FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease

Alterations in the Gut Microbiota and Serum Metabolomics of Spontaneous Cholestasis Caused by Loss of FXR Signal in Mice

Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis.

Mechanism of tissue‐specific farnesoid X receptor in suppressing the expression of genes in bile‐acid synthesis in mice

Deficiency of Intestinal Α1‐2‐fucosylation Exacerbates Ethanol‐Induced Liver Disease in Mice

A Villin-Driven Fxr Transgene Modulates Enterohepatic Bile Acid Homeostasis and Response to an n-6-Enriched High-Fat Diet

Deficiency of Both Farnesoid X Receptor and Takeda G Protein–Coupled Receptor 5 Exacerbated Liver Fibrosis in Mice